Alexandra Laura Mederle
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexandra Laura Mederle has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Borza
Department III Functional Sciences, Pathophysiology, “Victor Babeș” University of Medicine and Pharmacy of Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
6 shared publications - Adrian Cosmin Ilie
Department III Functional Science, Discipline of Public Health and Health Management, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
3 shared publications - Ana Lascu
Institute for Cardiovascular Diseases of Timișoara, “Victor Babeș” University of Medicine and Pharmacy Timișoara, Gheorghe Adam Street, No. 13A, 300310 Timișoara, Romania
3 shared publications - Nilima Rajpal Kundnani
Department VI—Cardiology, “Victor Babeş” University of Medicine and Pharmacy, 300041 Timisoara, Romania
3 shared publications - Ada-Maria Codreanu
Doctoral School, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
2 shared publications - Alexandru Caraba
Second Department of Internal Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
2 shared publications
Latest Publications
- Open Access
- 25 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (15) , 2336
Neurofunctional Changes Following Multimodal Rehabilitation Treatment in Patients with Cervical Spondylosis: An Exploratory Electrophysiological Study
Background/Objectives: This study aimed to assess nerve conduction studies (NCS) parameters of the median nerve and abductor pollicis brevis (APB) muscle activity in patients with cervical spondylosis. Additionally, we evaluated longitudinal changes in these parameters at six months following a multimodal rehabilitation treatment. Methods: This quasiexperimental, nonrandomized study included 41 patients with cervical spondylosis and 25 healthy controls. Median nerve conduction studies and semiquantitative surface electromyography (sEMG) of the APB muscle were assessed using a two-channel Neuro-MEP-Micro system (version 2009, Neurosoft Ltd.). The evaluations were performed at baseline in both groups and repeated after six months in the patient group. Pain intensity was assessed using the Visual Analog Scale (VAS). Results: Compared with controls, patients showed reduced compound muscle action potential (CMAP) amplitude (Cohen’s d = 1.53–1.83), slower motor conduction velocity (r = 0.91–0.95), and impaired sEMG amplitude and recruitment pattern of the APB muscle (all adjusted p < 0.001). After application of multimodal rehabilitation treatment, VAS scores decreased significantly (adjusted p < 0.001), and favorable changes in NCS and sEMG parameters were observed, with moderate to large effect sizes (Cohen’s d = 0.56–0.82; r = 0.52–0.86; all adjusted p ≤ 0.006). CMAP amplitude correlated positively with sEMG amplitude and recruitment pattern (ρ = 0.483–0.632, all adjusted p ≤ 0.001). Conclusions: Multimodal rehabilitation treatment may be associated with clinical and electrophysiological improvements, suggesting the complementary value of NCS and sEMG for the evaluation and follow-up of patients with cervical spondylosis. However, because of the nonrandomized uncontrolled design and the absence of longitudinal follow-up in controls, causal treatment effects cannot be inferred.
- 25 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (15) , 2336
Open AccessNeurofunctional Changes Following Multimodal Rehabilitation Treatment in Patients with Cervical Spondylosis: An Exploratory Electrophysiological Study
Background/Objectives: This study aimed to assess nerve conduction studies (NCS) parameters of the median nerve and abductor pollicis brevis (APB) muscle activity in patients with cervical spondylosis. Additionally, we evaluated longitudinal changes in these parameters at six months following a multimodal rehabilitation treatment. Methods: This quasiexperimental, nonrandomized study included 41 patients with cervical spondylosis and 25 healthy controls. Median nerve conduction studies and semiquantitative surface electromyography (sEMG) of the APB muscle were assessed using a two-channel Neuro-MEP-Micro system (version 2009, Neurosoft Ltd.). The evaluations were performed at baseline in both groups and repeated after six months in the patient group. Pain intensity was assessed using the Visual Analog Scale (VAS). Results: Compared with controls, patients showed reduced compound muscle action potential (CMAP) amplitude (Cohen’s d = 1.53–1.83), slower motor conduction velocity (r = 0.91–0.95), and impaired sEMG amplitude and recruitment pattern of the APB muscle (all adjusted p < 0.001). After application of multimodal rehabilitation treatment, VAS scores decreased significantly (adjusted p < 0.001), and favorable changes in NCS and sEMG parameters were observed, with moderate to large effect sizes (Cohen’s d = 0.56–0.82; r = 0.52–0.86; all adjusted p ≤ 0.006). CMAP amplitude correlated positively with sEMG amplitude and recruitment pattern (ρ = 0.483–0.632, all adjusted p ≤ 0.001). Conclusions: Multimodal rehabilitation treatment may be associated with clinical and electrophysiological improvements, suggesting the complementary value of NCS and sEMG for the evaluation and follow-up of patients with cervical spondylosis. However, because of the nonrandomized uncontrolled design and the absence of longitudinal follow-up in controls, causal treatment effects cannot be inferred.
- Open Access
- 20 July 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 894
Oxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting
Oxidative stress has emerged as an important component of the complex pathophysiology of inflammatory bowel disease (IBD), where increasing evidence suggests an interaction between redox imbalance, immune activation, epithelial dysfunction, and chronic intestinal inflammation. This structured narrative review critically synthesizes current evidence regarding the biological basis of oxidative stress in IBD, with emphasis on cellular and molecular mechanisms, oxidative biomarkers, therapeutic modulation of redox pathways, and their translational relevance. Current evidence indicates that oxidative stress is associated with immune-cell activation, mitochondrial dysfunction, impairment of epithelial homeostasis, and dysregulation of redox-sensitive signaling pathways. Biomarkers including nitric oxide metabolites, malondialdehyde, myeloperoxidase, total antioxidant capacity, serum thiols, and antioxidant enzymes have demonstrated associations with inflammatory activity, while anti-inflammatory, antioxidant, and dietary interventions have been reported to modulate oxidative biomarkers in selected clinical studies. However, substantial methodological heterogeneity, variability in analytical techniques, and limited prospective validation currently restrict their routine clinical application. Moreover, many mechanistic pathways have been characterized predominantly in experimental models, highlighting the need to distinguish biological plausibility from evidence supporting clinical implementation. Overall, oxidative stress represents a promising area of investigation that may contribute to a better understanding of IBD biology and support future biomarker-guided and precision medicine approaches. Nevertheless, further standardized translational and longitudinal clinical studies are required before oxidative biomarkers and redox-targeted strategies can be integrated into routine patient care.
- 20 July 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (7) , 894
Open AccessOxidative Stress in Inflammatory Bowel Disease: From Redox Dysregulation to Translational Targeting
Oxidative stress has emerged as an important component of the complex pathophysiology of inflammatory bowel disease (IBD), where increasing evidence suggests an interaction between redox imbalance, immune activation, epithelial dysfunction, and chronic intestinal inflammation. This structured narrative review critically synthesizes current evidence regarding the biological basis of oxidative stress in IBD, with emphasis on cellular and molecular mechanisms, oxidative biomarkers, therapeutic modulation of redox pathways, and their translational relevance. Current evidence indicates that oxidative stress is associated with immune-cell activation, mitochondrial dysfunction, impairment of epithelial homeostasis, and dysregulation of redox-sensitive signaling pathways. Biomarkers including nitric oxide metabolites, malondialdehyde, myeloperoxidase, total antioxidant capacity, serum thiols, and antioxidant enzymes have demonstrated associations with inflammatory activity, while anti-inflammatory, antioxidant, and dietary interventions have been reported to modulate oxidative biomarkers in selected clinical studies. However, substantial methodological heterogeneity, variability in analytical techniques, and limited prospective validation currently restrict their routine clinical application. Moreover, many mechanistic pathways have been characterized predominantly in experimental models, highlighting the need to distinguish biological plausibility from evidence supporting clinical implementation. Overall, oxidative stress represents a promising area of investigation that may contribute to a better understanding of IBD biology and support future biomarker-guided and precision medicine approaches. Nevertheless, further standardized translational and longitudinal clinical studies are required before oxidative biomarkers and redox-targeted strategies can be integrated into routine patient care.
- Open Access
- 21 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3970
Teledermoscopy-Assisted Referral for Cutaneous Melanoma: Diagnostic Timeliness, Histopathologic Severity, and Stage at Excision in a Comparative Cohort
Background/Objectives: Teledermoscopy may improve melanoma triage by accelerating specialist review and compressing the time to definitive treatment, but its clinical relevance depends on whether faster access is accompanied by detection at a less advanced stage. This study compared teledermoscopy-assisted and conventional referral pathways for cutaneous melanoma as a pathway-level service evaluation. Methods: In this single-center observational cohort, 87 patients with histologically confirmed primary cutaneous melanoma were analyzed, including 43 managed through teledermoscopy-assisted referral and 44 through a conventional pathway. Primary outcomes were time from referral to dermatology consultation, biopsy, and definitive excision. Secondary outcomes included Breslow thickness, mitotic rate, ulceration, stage distribution, early-stage disease, and selected pathway-quality indicators. Results: Teledermoscopy-assisted referral was associated with shorter median times to consultation (9.0 vs. 18.7 days), biopsy (16.6 vs. 30.3 days), and excision (26.9 vs. 43.2 days), all p < 0.001. Patients in the teledermoscopy group had lower Breslow thickness (0.7 vs. 1.5 mm, p < 0.001), lower mitotic rate (1.2 vs. 2.9 mitoses/mm2, p < 0.001), a higher proportion of stage 0/I melanoma (79.1% vs. 40.9%; risk ratio 1.93, 95% CI 1.31–2.85), and fewer lesions with Breslow > 2.0 mm (9.3% vs. 36.4%; risk ratio 0.26, 95% CI 0.09–0.70). Conclusions: In this non-randomized cohort, teledermoscopy-assisted referral was associated with faster melanoma care and a more favorable stage profile at excision. Because pathway assignment was not randomized and lesion-level referral urgency was incompletely measured, these findings should be interpreted as associations that support further prospective evaluation rather than as proof of causal stage migration.
- 21 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3970
Open AccessTeledermoscopy-Assisted Referral for Cutaneous Melanoma: Diagnostic Timeliness, Histopathologic Severity, and Stage at Excision in a Comparative Cohort
Background/Objectives: Teledermoscopy may improve melanoma triage by accelerating specialist review and compressing the time to definitive treatment, but its clinical relevance depends on whether faster access is accompanied by detection at a less advanced stage. This study compared teledermoscopy-assisted and conventional referral pathways for cutaneous melanoma as a pathway-level service evaluation. Methods: In this single-center observational cohort, 87 patients with histologically confirmed primary cutaneous melanoma were analyzed, including 43 managed through teledermoscopy-assisted referral and 44 through a conventional pathway. Primary outcomes were time from referral to dermatology consultation, biopsy, and definitive excision. Secondary outcomes included Breslow thickness, mitotic rate, ulceration, stage distribution, early-stage disease, and selected pathway-quality indicators. Results: Teledermoscopy-assisted referral was associated with shorter median times to consultation (9.0 vs. 18.7 days), biopsy (16.6 vs. 30.3 days), and excision (26.9 vs. 43.2 days), all p < 0.001. Patients in the teledermoscopy group had lower Breslow thickness (0.7 vs. 1.5 mm, p < 0.001), lower mitotic rate (1.2 vs. 2.9 mitoses/mm2, p < 0.001), a higher proportion of stage 0/I melanoma (79.1% vs. 40.9%; risk ratio 1.93, 95% CI 1.31–2.85), and fewer lesions with Breslow > 2.0 mm (9.3% vs. 36.4%; risk ratio 0.26, 95% CI 0.09–0.70). Conclusions: In this non-randomized cohort, teledermoscopy-assisted referral was associated with faster melanoma care and a more favorable stage profile at excision. Because pathway assignment was not randomized and lesion-level referral urgency was incompletely measured, these findings should be interpreted as associations that support further prospective evaluation rather than as proof of causal stage migration.
- Open Access
Relationships Between the Microvascular Network and Mast Cell Density in Malignant Melanoma
Background and Objectives: Angiogenesis plays an important role in many types of cancers, including melanoma. Mast cells are among the most important cellular partners involved in the angiogenic process. The purpose of the present study is to establish the interrelations between microvessels and mast cell density, and to describe the prognostic role of mast cells in malignant melanoma. Materials and Methods: A total of 92 cases of melanoma were evaluated. Hematoxylin–eosin staining and CD34/mast cell tryptase double immunostaining were performed. Results: Of the cases, 28 were classified as T1 (30.43%), 31 as T2 (33.69%), 21 as T3 (22.82%), and 12 as T4 (13.04%). Mast cells were mainly located in the infiltrate area in cases with inflammatory infiltrate. Few mast cells were observed in the absence of infiltrate. A granular type was observed in intratumoral areas with an isolated and perivascular distribution of mast cells. A significant correlation was found between intratumoral MVD and intratumoral MCD (mast cell density) in T1 and T4 melanoma cases (p = 0.0001 and p = 0.0029, respectively). In T2 cases, significant correlations were found between intratumoral and peritumoral MVD and G (p = 0.0169, p = 0.0003), between intratumoral MCD and MVD (p = 0.0041), and between peritumoral MVD and the number of peritumoral mast cells (p = 0.0011). T3 cases showed a significant correlation between the density of intratumoral mast cells and peritumoral ones (p = 0.001); between the MVD and mast cell density of the intratumoral area (p = 0.0001); between the intratumoral MVD and peritumoral mast cell density (p = 0.0001); between the MVD and mast cell density of the peritumoral area (p = 0.0325); and between the peritumoral MVD and intratumoral mast cell density (p = 0.0458). Conclusions: Both intratumoral and peritumoral mast cells were found to participate in melanoma progression, and they showed greater involvement in the early phases of angiogenesis in malignant melanoma.
Open AccessRelationships Between the Microvascular Network and Mast Cell Density in Malignant Melanoma
Background and Objectives: Angiogenesis plays an important role in many types of cancers, including melanoma. Mast cells are among the most important cellular partners involved in the angiogenic process. The purpose of the present study is to establish the interrelations between microvessels and mast cell density, and to describe the prognostic role of mast cells in malignant melanoma. Materials and Methods: A total of 92 cases of melanoma were evaluated. Hematoxylin–eosin staining and CD34/mast cell tryptase double immunostaining were performed. Results: Of the cases, 28 were classified as T1 (30.43%), 31 as T2 (33.69%), 21 as T3 (22.82%), and 12 as T4 (13.04%). Mast cells were mainly located in the infiltrate area in cases with inflammatory infiltrate. Few mast cells were observed in the absence of infiltrate. A granular type was observed in intratumoral areas with an isolated and perivascular distribution of mast cells. A significant correlation was found between intratumoral MVD and intratumoral MCD (mast cell density) in T1 and T4 melanoma cases (p = 0.0001 and p = 0.0029, respectively). In T2 cases, significant correlations were found between intratumoral and peritumoral MVD and G (p = 0.0169, p = 0.0003), between intratumoral MCD and MVD (p = 0.0041), and between peritumoral MVD and the number of peritumoral mast cells (p = 0.0011). T3 cases showed a significant correlation between the density of intratumoral mast cells and peritumoral ones (p = 0.001); between the MVD and mast cell density of the intratumoral area (p = 0.0001); between the intratumoral MVD and peritumoral mast cell density (p = 0.0001); between the MVD and mast cell density of the peritumoral area (p = 0.0325); and between the peritumoral MVD and intratumoral mast cell density (p = 0.0458). Conclusions: Both intratumoral and peritumoral mast cells were found to participate in melanoma progression, and they showed greater involvement in the early phases of angiogenesis in malignant melanoma.
- Open Access
- 9 March 2026
- Published by MDPI AG in Journal of Functional Morphology and Kinesiology
- Vol. 11 (1) , 114
Neurofunctional Assessments in Lumbar Spondylosis: Outcomes After Rehabilitation Treatment
Background: Lumbar spondylosis is a frequent cause of chronic low back pain, often associated with radiculopathy. Although imaging evaluation is widely used, it does not always reflect the degree of functional impairment of the nerve roots. Electrophysiological assessments, such as nerve conduction studies (NCS) and surface electromyography (sEMG), can provide additional information on neuromuscular function under conservative treatment. Methods: This quasi-experimental study included 60 patients with lumbar spondylosis and 25 healthy subjects, who underwent clinical, imaging, and electrophysiological assessments. NCS and sEMG parameters were assessed in the patient group before and six months after rehabilitation treatment. The control group was assessed only once, at baseline. We analyzed the nerve conduction velocity of the tibial and peroneal nerves and the sEMG activity of the tibialis anterior muscle bilaterally. Statistical analysis used nonparametric tests, Spearman’s coefficient, and Hodges–Lehmann estimates. Results: Compared to the control group, patients presented increased residual latencies and reduced CMAP amplitude and motor conduction velocity values (p < 0.001). After rehabilitation treatment, significant improvements in NCS parameters were observed, with decreased latencies and increased CMAP amplitude and motor conduction velocity bilaterally (p < 0.001). Also, sEMG amplitude and recruitment pattern scores increased significantly at the 6-month follow-up (p ≤ 0.004). Correlations between electrophysiological parameters and the severity of imaging changes were limited, with modest associations for left tibial latencies (ρ = 0.401–0.467; p < 0.050). Conclusions: In patients with lumbar spondylosis, rehabilitation treatment was associated with functional improvements in nerve conduction velocity parameters and muscle activity.
- 9 March 2026
- Published by MDPI AG in Journal of Functional Morphology and Kinesiology
- Vol. 11 (1) , 114
Open AccessNeurofunctional Assessments in Lumbar Spondylosis: Outcomes After Rehabilitation Treatment
Background: Lumbar spondylosis is a frequent cause of chronic low back pain, often associated with radiculopathy. Although imaging evaluation is widely used, it does not always reflect the degree of functional impairment of the nerve roots. Electrophysiological assessments, such as nerve conduction studies (NCS) and surface electromyography (sEMG), can provide additional information on neuromuscular function under conservative treatment. Methods: This quasi-experimental study included 60 patients with lumbar spondylosis and 25 healthy subjects, who underwent clinical, imaging, and electrophysiological assessments. NCS and sEMG parameters were assessed in the patient group before and six months after rehabilitation treatment. The control group was assessed only once, at baseline. We analyzed the nerve conduction velocity of the tibial and peroneal nerves and the sEMG activity of the tibialis anterior muscle bilaterally. Statistical analysis used nonparametric tests, Spearman’s coefficient, and Hodges–Lehmann estimates. Results: Compared to the control group, patients presented increased residual latencies and reduced CMAP amplitude and motor conduction velocity values (p < 0.001). After rehabilitation treatment, significant improvements in NCS parameters were observed, with decreased latencies and increased CMAP amplitude and motor conduction velocity bilaterally (p < 0.001). Also, sEMG amplitude and recruitment pattern scores increased significantly at the 6-month follow-up (p ≤ 0.004). Correlations between electrophysiological parameters and the severity of imaging changes were limited, with modest associations for left tibial latencies (ρ = 0.401–0.467; p < 0.050). Conclusions: In patients with lumbar spondylosis, rehabilitation treatment was associated with functional improvements in nerve conduction velocity parameters and muscle activity.
- Open Access
- 26 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 3003
Teledermatology and Teledermoscopy for Melanoma Care Pathways: Timeliness, Diagnostic Performance, and Stage at Diagnosis: A Systematic Review
Background/Objectives: Early melanoma management depends on rapid triage and definitive treatment. Image-enabled teledermatology, particularly teledermoscopy, may accelerate pathways without compromising safety. This review evaluated effects on timeliness, diagnostic performance, and initial prognostic severity at diagnosis. Methods: Following a preregistered PRISMA-2020 protocol, PubMed/MEDLINE, Embase, and Scopus were searched from inception to 1 September 2025. Comparative clinical studies and service evaluations reporting melanoma-specific outcomes were eligible. Dual screening, duplicate data extraction, and risk-of-bias appraisal were performed; substantial clinical and methodological heterogeneity precluded quantitative meta-analysis, so findings were synthesized narratively. Results: Twelve studies met criteria. Front-end intervals consistently shortened: time to expert advice was ≈1 day and median time to first clinic was reduced by ~10 days versus conventional referral. Downstream milestones showed mixed translation, with time to excision and histology in several programs remaining ≈45–67 days, indicating capacity constraints beyond triage. Diagnostic safety was high where quantified: melanoma triage sensitivity approached ~99% with a false-negative rate near ~1.1%, and positive predictive value for suspected-melanoma referrals was ~45–50% in mature services. Selected observational comparisons suggested a ≈0.6 mm lower mean Breslow thickness and ~13-percentage-point higher in situ/T1 proportion in one TD network, although these findings are susceptible to selection and lead-time bias and are not consistent across all settings. Overall, teledermoscopy functioned as a “front-door accelerator,” with pathway gains being largest before surgical and pathology steps. Conclusions: Teledermatology/teledermoscopy reliably compresses referral-to-decision intervals and maintains high triage safety, with indications of stage migration toward thinner tumors at diagnosis. Integrating surgical and pathology capacity is essential to convert early advice into earlier definitive treatment.
- 26 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 3003
Open AccessTeledermatology and Teledermoscopy for Melanoma Care Pathways: Timeliness, Diagnostic Performance, and Stage at Diagnosis: A Systematic Review
Background/Objectives: Early melanoma management depends on rapid triage and definitive treatment. Image-enabled teledermatology, particularly teledermoscopy, may accelerate pathways without compromising safety. This review evaluated effects on timeliness, diagnostic performance, and initial prognostic severity at diagnosis. Methods: Following a preregistered PRISMA-2020 protocol, PubMed/MEDLINE, Embase, and Scopus were searched from inception to 1 September 2025. Comparative clinical studies and service evaluations reporting melanoma-specific outcomes were eligible. Dual screening, duplicate data extraction, and risk-of-bias appraisal were performed; substantial clinical and methodological heterogeneity precluded quantitative meta-analysis, so findings were synthesized narratively. Results: Twelve studies met criteria. Front-end intervals consistently shortened: time to expert advice was ≈1 day and median time to first clinic was reduced by ~10 days versus conventional referral. Downstream milestones showed mixed translation, with time to excision and histology in several programs remaining ≈45–67 days, indicating capacity constraints beyond triage. Diagnostic safety was high where quantified: melanoma triage sensitivity approached ~99% with a false-negative rate near ~1.1%, and positive predictive value for suspected-melanoma referrals was ~45–50% in mature services. Selected observational comparisons suggested a ≈0.6 mm lower mean Breslow thickness and ~13-percentage-point higher in situ/T1 proportion in one TD network, although these findings are susceptible to selection and lead-time bias and are not consistent across all settings. Overall, teledermoscopy functioned as a “front-door accelerator,” with pathway gains being largest before surgical and pathology steps. Conclusions: Teledermatology/teledermoscopy reliably compresses referral-to-decision intervals and maintains high triage safety, with indications of stage migration toward thinner tumors at diagnosis. Integrating surgical and pathology capacity is essential to convert early advice into earlier definitive treatment.
- Open Access
- 22 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2316
Comparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis
Background/Objectives: Dry eye disease (DED) is a prevalent, complex disorder with a major impact on patients’ quality of life. While artificial tears (AT) are still the first-line treatment, their effectiveness is often limited in moderate-to-severe cases. Autologous serum (AS) and platelet-rich plasma (PRP) are now recognized as viable biologic treatments due to their regenerative and anti-inflammatory characteristics. This systematic review and meta-analysis sought to assess and compare the clinical efficacy of PRP, AS, and AT in the treatment of DED, with a focus on comparative studies. Methods: A comprehensive search of PubMed, Scopus, and Google Scholar was conducted until June 2025 for studies directly comparing PRP, AS, and AT. Eligible trials included patients with DED who reported results such as the Schirmer test, tear break-up time (TBUT), and Ocular Surface Disease Index (OSDI). The risk of bias was calculated using ROB 2 for randomized trials and ROBINS-I for non-randomized studies. Meta-analyses were carried out using standardized mean differences (SMDs) and 95% confidence intervals (CIs). Results: Seventeen studies were included in the systematic review. Both PRP and AS demonstrated greater improvements in OSDI, TBUT, and Schirmer test scores compared to AT. PRP showed a trend toward better outcomes than AS, especially in studies using injectable PRP. However, substantial heterogeneity and methodological variability were noted. Conclusions: Comparative research suggests that PRP and AS are more effective than AT in treating DED. Direct comparisons of PRP and AS yield varied results, with the route of delivery impacting outcomes. Given the heterogeneity of current protocols, further standardized, long-term trials are required to confirm the optimal delivery method and ensure safety.
- 22 September 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (9) , 2316
Open AccessComparative Efficacy of Platelet-Rich Plasma, Autologous Serum, and Artificial Tears in Dry Eye Disease: A Systematic Review and Meta-Analysis
Background/Objectives: Dry eye disease (DED) is a prevalent, complex disorder with a major impact on patients’ quality of life. While artificial tears (AT) are still the first-line treatment, their effectiveness is often limited in moderate-to-severe cases. Autologous serum (AS) and platelet-rich plasma (PRP) are now recognized as viable biologic treatments due to their regenerative and anti-inflammatory characteristics. This systematic review and meta-analysis sought to assess and compare the clinical efficacy of PRP, AS, and AT in the treatment of DED, with a focus on comparative studies. Methods: A comprehensive search of PubMed, Scopus, and Google Scholar was conducted until June 2025 for studies directly comparing PRP, AS, and AT. Eligible trials included patients with DED who reported results such as the Schirmer test, tear break-up time (TBUT), and Ocular Surface Disease Index (OSDI). The risk of bias was calculated using ROB 2 for randomized trials and ROBINS-I for non-randomized studies. Meta-analyses were carried out using standardized mean differences (SMDs) and 95% confidence intervals (CIs). Results: Seventeen studies were included in the systematic review. Both PRP and AS demonstrated greater improvements in OSDI, TBUT, and Schirmer test scores compared to AT. PRP showed a trend toward better outcomes than AS, especially in studies using injectable PRP. However, substantial heterogeneity and methodological variability were noted. Conclusions: Comparative research suggests that PRP and AS are more effective than AT in treating DED. Direct comparisons of PRP and AS yield varied results, with the route of delivery impacting outcomes. Given the heterogeneity of current protocols, further standardized, long-term trials are required to confirm the optimal delivery method and ensure safety.
- Open Access
Efficacy of Neurorehabilitation Approaches in Traumatic Brain Injury Patients: A Comprehensive Review
Traumatic brain injury (TBI) represents a significant public health issue, causing long-term disabilities and imposing considerable socioeconomic and healthcare challenges. While advancements in acute care have improved survival rates, the demand for effective neurorehabilitation is increasing. This narrative review explores the evidence on neurorehabilitation strategies for TBI, focusing on interventions targeting cognitive, motor, and psychological recovery. A total of 32 studies were included and categorized into six approaches: non-invasive brain stimulation, virtual reality (VR), computer-based training, telerehabilitation, robot-assisted therapy (RAT), and mixed approaches. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), showed variable effectiveness in improving cognitive outcomes. VR-based therapies enhanced attention and executive functions, while RAT, such as Lokomat and exoskeletons, improved gait symmetry and functional mobility. Computer-assisted programs demonstrated benefits in rehabilitating social cognition and executive functions. Telerehabilitation and telephone-based treatments provided short-term gains but lacked sustained effects. Overall, cognitive improvements were better described and represented, while several motor improvements lacked consistency. Despite the promising results, significant gaps remain, including heterogeneity in methodologies, small sample sizes, and limited long-term outcome data.
Open AccessEfficacy of Neurorehabilitation Approaches in Traumatic Brain Injury Patients: A Comprehensive Review
Traumatic brain injury (TBI) represents a significant public health issue, causing long-term disabilities and imposing considerable socioeconomic and healthcare challenges. While advancements in acute care have improved survival rates, the demand for effective neurorehabilitation is increasing. This narrative review explores the evidence on neurorehabilitation strategies for TBI, focusing on interventions targeting cognitive, motor, and psychological recovery. A total of 32 studies were included and categorized into six approaches: non-invasive brain stimulation, virtual reality (VR), computer-based training, telerehabilitation, robot-assisted therapy (RAT), and mixed approaches. Non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), showed variable effectiveness in improving cognitive outcomes. VR-based therapies enhanced attention and executive functions, while RAT, such as Lokomat and exoskeletons, improved gait symmetry and functional mobility. Computer-assisted programs demonstrated benefits in rehabilitating social cognition and executive functions. Telerehabilitation and telephone-based treatments provided short-term gains but lacked sustained effects. Overall, cognitive improvements were better described and represented, while several motor improvements lacked consistency. Despite the promising results, significant gaps remain, including heterogeneity in methodologies, small sample sizes, and limited long-term outcome data.
- Open Access
Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy
Background and Objectives: Sodium butyrate (NaB) is a potent modulator of cancer-related gene networks. However, its precise mechanisms of action and effects at elevated doses remain insufficiently explored. This study investigated the impact of NaB at physiologically relevant doses on key cellular metrics (viability, confluence, cell number, morphology, nuclear integrity) and a comprehensive set of apoptosis and proliferation regulators (including underexplored genes) in colorectal cancer (CRC) cells. Materials and Methods: Human HCT-116 cells were treated with increasing NaB concentrations (0–20 mM). Cell viability, confluence, number, morphology, and nuclear integrity were assessed using MTT and imaging assays. RT-PCR was used to determine changes in the expression of critical pro-apoptotic players (BAX, CASP3, PUMA, TP53), anti-apoptotic facilitators (BCL-2, MCL-1), cell division regulators (PCNA, Ki-67, CDKN1), and inflammation genes (NF-κB). Results: This study provides the first exploration of MCL-1 and PCNA modulation by NaB in the context of CRC and HCT-116 cells, offering significant translational insights. All treatments reduced cell viability, confluence, and number in a dose-dependent manner (p < 0.0001). Gene expression revealed dose-related increases in most pro-apoptotic markers (BAX, CASP3, PUMA; p < 0.001), and decreases for the other genes (p < 0.001). BAX emerged as the most responsive gene to NaB, while TP53 showed minimal sensitivity, supporting NaB’s effectiveness in p53-compromised phenotypes. Nuclear condensation and fragmentation at higher NaB doses confirmed apoptotic induction. Conclusions: NaB can modulate critical apoptotic and cell cycle genes, disrupt tumor cell proliferation, and overcome resistance mechanisms associated with anti-apoptotic regulators such as MCL-1. By targeting both short-term and long-term anti-apoptotic defenses, NaB shows promise as a preventive and therapeutic agent in CRC, particularly in high-risk phenotypes with compromised p53 functionality. These findings support its potential for integration into combination therapies or dietary interventions aimed at enhancing colonic butyrate levels.
Open AccessSodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy
Background and Objectives: Sodium butyrate (NaB) is a potent modulator of cancer-related gene networks. However, its precise mechanisms of action and effects at elevated doses remain insufficiently explored. This study investigated the impact of NaB at physiologically relevant doses on key cellular metrics (viability, confluence, cell number, morphology, nuclear integrity) and a comprehensive set of apoptosis and proliferation regulators (including underexplored genes) in colorectal cancer (CRC) cells. Materials and Methods: Human HCT-116 cells were treated with increasing NaB concentrations (0–20 mM). Cell viability, confluence, number, morphology, and nuclear integrity were assessed using MTT and imaging assays. RT-PCR was used to determine changes in the expression of critical pro-apoptotic players (BAX, CASP3, PUMA, TP53), anti-apoptotic facilitators (BCL-2, MCL-1), cell division regulators (PCNA, Ki-67, CDKN1), and inflammation genes (NF-κB). Results: This study provides the first exploration of MCL-1 and PCNA modulation by NaB in the context of CRC and HCT-116 cells, offering significant translational insights. All treatments reduced cell viability, confluence, and number in a dose-dependent manner (p < 0.0001). Gene expression revealed dose-related increases in most pro-apoptotic markers (BAX, CASP3, PUMA; p < 0.001), and decreases for the other genes (p < 0.001). BAX emerged as the most responsive gene to NaB, while TP53 showed minimal sensitivity, supporting NaB’s effectiveness in p53-compromised phenotypes. Nuclear condensation and fragmentation at higher NaB doses confirmed apoptotic induction. Conclusions: NaB can modulate critical apoptotic and cell cycle genes, disrupt tumor cell proliferation, and overcome resistance mechanisms associated with anti-apoptotic regulators such as MCL-1. By targeting both short-term and long-term anti-apoptotic defenses, NaB shows promise as a preventive and therapeutic agent in CRC, particularly in high-risk phenotypes with compromised p53 functionality. These findings support its potential for integration into combination therapies or dietary interventions aimed at enhancing colonic butyrate levels.
- Open Access
- 31 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 188
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
Diabetes is a complex global healthcare burden involving multiple organ systems with its prevalence on the rise. SGLT2 inhibitors enhance glucose excretion. The objective of our literature review was to determine the association between cutaneous adverse drug reactions (CADRs) and the use of SGLT2 inhibitors. We collected data on CADRs related to the use of SGLT2 inhibitors from all available published articles and studied their details to understand the patterns of their association. PubMed, Cochrane, Google, and Embase were searched for relevant articles. A total of 37 papers were included and studied. Most articles were case reports followed by pharmacovigilance studies, case series, and reviews. The cutaneous findings ranged from benign eruptions to severe reactions. The available literature suggests a strong link between the use of SGLT2 inhibitors and Fournier’s gangrene/necrotizing fasciitis. T2DM patients using SGLT2 inhibitors have also developed fixed drug eruptions, drug-induced pruritus, and Sweet syndrome/acute febrile neutrophilic dermatosis, among other skin lesions. We found that SGLT2 inhibitors present a risk of developing CADRs. Raising awareness among healthcare providers regarding CADRs to SGLT2 inhibitors can reduce complications, minimize hospitalizations, and improve patient care in the vulnerable population of diabetes patients.
- 31 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (1) , 188
Open AccessCutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
Diabetes is a complex global healthcare burden involving multiple organ systems with its prevalence on the rise. SGLT2 inhibitors enhance glucose excretion. The objective of our literature review was to determine the association between cutaneous adverse drug reactions (CADRs) and the use of SGLT2 inhibitors. We collected data on CADRs related to the use of SGLT2 inhibitors from all available published articles and studied their details to understand the patterns of their association. PubMed, Cochrane, Google, and Embase were searched for relevant articles. A total of 37 papers were included and studied. Most articles were case reports followed by pharmacovigilance studies, case series, and reviews. The cutaneous findings ranged from benign eruptions to severe reactions. The available literature suggests a strong link between the use of SGLT2 inhibitors and Fournier’s gangrene/necrotizing fasciitis. T2DM patients using SGLT2 inhibitors have also developed fixed drug eruptions, drug-induced pruritus, and Sweet syndrome/acute febrile neutrophilic dermatosis, among other skin lesions. We found that SGLT2 inhibitors present a risk of developing CADRs. Raising awareness among healthcare providers regarding CADRs to SGLT2 inhibitors can reduce complications, minimize hospitalizations, and improve patient care in the vulnerable population of diabetes patients.